Literature DB >> 2558901

Modulation of uterine GABAA receptors during gestation and by tetrahydroprogesterone.

M D Majewska1, G Falkay, E E Baulieu.   

Abstract

Binding of a GABAA receptor agonist, [3H]muscimol, was studied in rat uterine membranes of non-pregnant rats and those at days 15 and 19 of pregnancy. Also, an interaction of the uterine GABAA receptors with tetrahydroprogesterone was examined. At day 15 of gestation [3H]muscimol binding was twice as high as in non-pregnant rats, but at day 19 it was reduced. These changes resulted from an increase of the receptor affinity and decrease of the receptor density, at days 15 and 19, respectively. Since tetrahydroprogesterone, in vitro, also increased [3H]muscimol binding, we propose that this steroid may participate in regulation of uterine function during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558901     DOI: 10.1016/0014-2999(89)90871-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

Review 1.  Olfaction, GABAergic neurotransmission in the olfactory bulb, and intermale aggression in mice: modulation by steroids.

Authors:  P V Guillot; G Chapouthier
Journal:  Behav Genet       Date:  1996-09       Impact factor: 2.805

2.  Neurosteroids increase tonic GABAergic inhibition in the lateral section of the central amygdala in mice.

Authors:  H Romo-Parra; P Blaesse; L Sosulina; H-C Pape
Journal:  J Neurophysiol       Date:  2015-03-18       Impact factor: 2.714

3.  The antidepressant-like effect of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane involves a regulation of β-type estrogen receptors.

Authors:  Julie Espallergues; Jamal Temsamani; Claude Laruelle; Alexandre Urani; Tangui Maurice
Journal:  Psychopharmacology (Berl)       Date:  2010-10-28       Impact factor: 4.530

4.  Estrous cycle, pregnancy, and parity enhance performance of rats in object recognition or object placement tasks.

Authors:  Jason J Paris; Cheryl A Frye
Journal:  Reproduction       Date:  2008-04-04       Impact factor: 3.906

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.